News

Certain antibodies blocked nearly 70% of HIV strains, including those typically hard to target.

Chi-Huey Wong Laboratories for Biomedical Research recognized for sustainable construction.

The ceremony represented the largest graduating class since the doctoral program’s inception in 1989.

President and CEO Pete Schultz is honored for expanding the genetic code and the development and application of large scale “diversity-based” approaches to the discovery of novel proteins, drugs and modern materials.

Researchers show that mpox circulated among humans in Nigeria for eight years before the international outbreak, highlighting the need for improved surveillance.

North American and African clinical trials led by Scripps Research, IAVI and additional collaborators across the U.S. and Africa mark progress toward an effective HIV vaccine.

Breakthrough from Scripps Research, the San Diego Zoo Wildlife Alliance, Max Planck Institute and other collaborators paves way for stem cell-based reproduction.

Latest book by Scripps Research executive vice president guides readers through medical breakthroughs that are primed to extend healthspan

Scripps Research scientists used computer modeling to illustrate how antibodies use fatty molecules known as lipids to recognize the HIV virus.

Scripps Research and Georgia Institute of Technology scientists’ discovery could help understand how life evolved on Earth and lead to better biofuel production.

Scripps Research scientists find that apremilast, an FDA-approved anti-inflammatory drug, reduced both drinking and pain sensitivity in preclinical models of alcohol use disorder.

Scripps Research scientists discover that a higher ratio of antibodies to viral protein helps engage two specific types of immune cells.

Scripps Research scientists developed a model that more accurately identifies patients at risk of coronary artery disease and can inform tailored treatment.

New insights from Scripps Research could advance phage therapies for the world’s deadliest bacteria—including drug-resistant strains.

Innovative cellular therapy has potential to treat patients with lupus, systemic sclerosis, myositis and RA without chemotherapy-induced immune suppression.

Scripps Research and aTyr Pharma scientists have revealed how the protein HARSWHEP calms inflammation associated with sarcoidosis.

Scripps Research scientists reveal that microRNAs guide the development of Purkinje cells, a rare type of neuron linked to neurodevelopmental disorders.

Researchers reprogrammed a botulinum toxin protease to selectively break down disease-causing proteins in human cells, providing proof of concept for developing new therapies for a wide range of illnesses.

Scripps Research chemistry professor Chi-Huey Wong presents results from his team’s studies at the ACS Spring 2025 Digital Meeting.

New structural hallmarks of memory storage discovered by Scripps Research could lead to treatments for memory loss.

Scripps Research scientists created a stable form of carnosic acid, observing greater memory function and other disease improvements in mice.

New structural blueprint is key for better targeting cancer cells, particularly those with BRCA1 and 2 mutations.

Scripps Research scientists discovered how a chemical modification of a key brain protein—potentially triggered by climate change-induced air pollution, pesticides, wildfires and processed meats—disrupts normal brain cell function.

ADA’s $1.3 million grant will support the Droujinine lab’s research of interorgan dialogue to develop therapeutics for diabetes management.